Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional Study Evaluating the Effect of Epigallocatechin Gallate (EGCG), Folic Acid (FA), Vitamin B12 (B12) and Hyaluronic Acid (HA) in Affecting the DNA Integration of Human Papilloma Virus (HPV) in Women With Persistent Infection

NCT07697196 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07697196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07697196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional Study Evaluating the Effect of Epigallocatechin Gallate (EGCG), Folic Acid (FA), Vitamin B12 (B12) and Hyaluronic Acid (HA) in Affecting the DNA Integration of Human Papilloma Virus (HPV) in Women With Persistent Infection
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
June 30, 2028
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv disease, hpv genital infection, hpv infection, hpv integration, hpv persistence, low grade squamous intraepithelial lesions of the cervix